P
RMD icon

Pitcairn’s ResMed RMD Stock Holding History

Pitcairn’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-744
Closed -$204K – 454
2025
Q3 		$204K Sell
744
-152
-17% -$41.5K 0.02% 604
2025
Q2 		$231K Sell
896
-146
-14% -$34.8K 0.02% 640
2025
Q1 		$233K Sell
1,042
-1
-0.1% -$233 0.01% 652
2024
Q4 		$239K Sell
1,043
-3
-0.3% -$722 0.01% 643
2024
Q3 		$255K Sell
1,046
-166
-14% -$37.1K 0.02% 634
2024
Q2 		$232K Buy
1,212
+107
+10% +$21.7K 0.01% 658
2024
Q1 		$219K Buy
+1,105
New +$202K 0.01% 670
2021
Q1 		– Sell
-1,124
Closed -$239K – 623
2020
Q4 		$239K Buy
+1,124
New +$224K 0.02% 515
2020
Q3 		– Sell
-1,057
Closed -$203K – 538
2020
Q2 		$203K Buy
+1,057
New +$173K 0.02% 468

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Pitcairn's RMD Position: Q4 2025 in Review

Pitcairn sold out of ResMed (RMD) in Q4 2025, closing a stake of 744 shares — an estimated $204K sold.

Pitcairn first reported a position in RMD in Q2 2020 and held it in 9 quarters. The position peaked at $255K in Q3 2024. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Pitcairn reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 744 ResMed shares in Q4 2025, an estimated $204K.
  • Pitcairn first reported a position in ResMed in Q2 2020 and held it in 9 quarters.
  • Pitcairn's ResMed position peaked at $255K in Q3 2024.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.